Annie Drelles
Senior Director, Medical Access, Global Oncology Medical Affairs Daiichi Sankyo
Annie Drelles is the Senior Director and Head of the Office of Medical Access within Global Oncology Medical Affairs at Daiichi Sankyo. With a robust background in medical affairs, she leads initiatives that bridge clinical research and patient access, ensuring that innovative oncology treatments reach patients in need. Her expertise encompasses early and expanded access programs, policy development, and cross-functional collaboration across global teams.
Seminars
Monday 23rd March 2026
Workshop D: Timing & Risk Management in EAP Strategy
9:00 am
- Preparing EAP infrastructure early without certainty of trial readouts or approvals
- Balancing investment risk vs. readiness: how much to build before the data arrives
- Understanding the real timelines for opening EAPs across different geographies
- Creating flexible plans that allow quick go/no-go decisions aligned to pivotal data milestones
Wednesday 25th March 2026
Navigating Global Differences & Business Decisions in Expanded Access Programs
11:30 am
- Compare regulatory frameworks and access pathways across the US (FDA), Europe (EMA), and other national systems such as France’s ATU
- Explore how approaches to expanded access differ between large pharma and smaller biotech organizations.
- Examine how companies assess the business case and operational feasibility of launching programs in emerging regions, including the Middle East and Latin America
